1-Piperidineethanol, α-(4-chlorophenyl)-4-[(4-fluorophenyl)methyl]-
| Title | Journal |
|---|---|
| Identification of potent Yes1 kinase inhibitors using a library screening approach. | Bioorganic & medicinal chemistry letters 20130801 |
| Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by ifenprodil: the role of sigma-1 and IP3 receptors. | PloS one 20120101 |
| A complex interaction between glycine/NMDA receptors and serotonergic/noradrenergic antidepressants in the forced swim test in mice. | Journal of neural transmission (Vienna, Austria : 1996) 20111101 |
| The effects of a single memantine treatment on behavioral alterations associated with binge alcohol exposure in neonatal rats. | Neurotoxicology and teratology 20110101 |
| Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review. | Journal of pharmacy & bioallied sciences 20110101 |
| Chiral Pharmaceutical Intermediaries Obtained by Reduction of 2-Halo-1-(4-substituted phenyl)-ethanones Mediated by Geotrichum candidum CCT 1205 and Rhodotorula glutinis CCT 2182. | Enzyme research 20110101 |
| Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols. | Bioorganic & medicinal chemistry 20101115 |
| Development of a selective competitive receptor binding assay for the determination of the affinity to NR2B containing NMDA receptors. | Journal of pharmaceutical and biomedical analysis 20101102 |
| The site specific demethylation in the 5'-regulatory area of NMDA receptor 2B subunit gene associated with CIE-induced up-regulation of transcription. | PloS one 20100101 |
| Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease. | Molecular neurodegeneration 20100101 |
| A systematic review of clinical trials of pharmacological interventions for acute ischaemic stroke (1955-2008) that were completed, but not published in full. | Trials 20100101 |
| A new homogeneous high-throughput screening assay for profiling compound activity on the human ether-a-go-go-related gene channel. | Analytical biochemistry 20091101 |
| Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. | Nature chemical biology 20091001 |
| Pharmacology and therapeutic potential of sigma(1) receptor ligands. | Current neuropharmacology 20081201 |
| Hypoxia-ischemia and retinal ganglion cell damage. | Clinical ophthalmology (Auckland, N.Z.) 20081201 |
| Alcohol related changes in regulation of NMDA receptor functions. | Current neuropharmacology 20080301 |
| Pigment epithelium-derived factor protects retinal ganglion cells. | BMC neuroscience 20070101 |
| Polyamines in the brain: distribution, biological interactions, and their potential therapeutic role in brain ischaemia. | Current medicinal chemistry 20070101 |
| The sequential analysis of repeated binary responses: a score test for the case of three time points. | Statistics in medicine 20060715 |
| Adaptation of USP types II and IV controlled release assays for sparingly soluble compounds by direct eluent HPLC analysis. | Pharmaceutical development and technology 20060201 |
| NMDA/NR2B selective antagonists in the treatment of ischemic brain injury. | Current drug targets. CNS and neurological disorders 20050401 |
| Administration of eliprodil during ethanol withdrawal in the neonatal rat attenuates ethanol-induced learning deficits. | Psychopharmacology 20040901 |
| Effect of a neuroprotective drug, eliprodil on cardiac repolarisation: importance of the decreased repolarisation reserve in the development of proarrhythmic risk. | British journal of pharmacology 20040901 |
| Glutamate-dependent regulation of cholinergic phenotype in hypothalamic neurons. | Neuroreport 20031219 |
| Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? | The Lancet. Neurology 20021001 |
| Site-selective N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonists produce distinct effects in rats performing complex discriminations. | Neurobiology of learning and memory 20020901 |
| Spermidine attenuates the inhibitory effect of ethanol on NMDA-induced neurotoxicity. | Naunyn-Schmiedeberg's archives of pharmacology 20020801 |
| Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. | The Journal of biological chemistry 20020419 |
| An MCASE approach to the search of a cure for Parkinson's Disease. | BMC pharmacology 20020101 |
| NR2B selective NMDA receptor antagonists. | Current pharmaceutical design 20020101 |
| Glutamate AMPA receptor antagonist treatment for ischaemic stroke. | Current medical research and opinion 20020101 |
| NMDA antagonists produce site-selective impairment of accuracy in a delayed nonmatch-to-sample task in rats. | Neuropharmacology 20011201 |
| The NMDA receptor complex: a promising target for novel antiepileptic strategies. | Current medicinal chemistry 20010901 |
| NMDA receptor antagonists do not block the development of sensitization of catalepsy, but make its expression state-dependent. | Behavioural pharmacology 20010401 |
| Central effects of SL 82.0715, an antagonist of polyamine site of the NMDA receptor complex. | Polish journal of pharmacology 19930101 |